Moderna Inc

These are the stocks posting the largest moves in midday trading.

The wealth of the world’s ten richest men doubled from $700 billion to $1.5 trillion during the pandemic, the global charity said in a press release on Monday.

These are the stocks posting the largest moves in midday trading.

U.S. stock futures rose slightly Thursday ahead of what’s expected to be another hot inflation report.

U.S. stock futures rose slightly Thursday after another hot but unsurprising inflation report.

These are the stocks posting the largest moves before the bell.

Cuba remains the only country in Latin America and the Caribbean to have produced a homegrown shot for Covid.

[The stream is slated to start at 10 a.m. ET. Please refresh the page if you do not see a player above at that time.] The top health leaders in the U.S. will testify before the Senate on Tuesday about the federal response to the omicron Covid variant, as new infections and hospitalizations reach pandemic highs. The Senate health...

Bourla said the two-dose vaccine has lost its protective power against infection and its ability to prevent hospitalization has also dropped.

Both Pfizer and Moderna have omicron-specific vaccines coming. But the targeted shot was needed in December to help stem the current wave, say experts.

These are the stocks posting the largest moves in midday trading.

Pfizer and Moderna are utilizing the same mRNA technology found in Covid-19 vaccines to try to develop a one-time universal flu cure.

Moderna CEO Stephane Bancel said the omicron-specific booster will enter clinical trials soon.

The shortened waiting period for boosters comes as data shows that two doses do not provide strong protection against symptomatic infection from omicron.

U.S. stock futures fell Friday after the government’s latest employment report showed much weaker-than-expected job growth.

U.S. stock futures fell Friday after the government’s latest employment report showed much weaker-than-expected job growth.

Moderna CEO Stephane Bancel said the efficacy of boosters against Covid-19 will likely decline over time, and some people may need a fourth shot by the fall. “I would expect that it’s not going to hold great,” Bancel said, during a Goldman Sachs interview, referring to the strength of the single booster shots. A random mutation could change the...

There are early, tentative signs that the omicron wave has peaked, or is plateauing, in the places that were among the first to be hit hard by the variant.

“Many of these Nasdaq winners have fallen out of favor and become incredibly dangerous,” the “Mad Money” host said.

The omicron variant now represents nearly every Covid case sequenced by the Centers for Disease Control and Prevention.